News

Stay up to date with the latest Synexa news and updates

June 11, 2025

Synexa Life Sciences Achieves Gyrolab CRO Certification

We are proud to announce that Synexa Life Sciences has been awarded Gyrolab CRO certification, recognising our expertise in advanced...
Laboratory equipment in a research facility.

June 10, 2025

Synexa Life Sciences Partners with Waters to Trial Xevo TQ Absolute XR Mass Spectrometer

Synexa Life Sciences is pleased to announce its collaboration with Waters Corporation as one of the first bioanalytical laboratories to...

February 4, 2025

Synexa Life Sciences Achieves Highest Level My Green Lab Certification, Reinforcing Commitment to Lab Sustainability

Synexa Life Sciences has proudly achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town,...

January 30, 2025

Sally Hannam Strengthens Synexa’s Scientific Expertise as Scientific Director

Synexa Life Sciences is pleased to announce Sally Hannam as the latest addition to the Synexa Life Sciences' Scientific Strategies...

January 24, 2025

Paul Holme joins the Synexa Global Management Team as Chief Operating Officer

Synexa Life Sciences is proud to welcome Paul Holme to its Global Management Team as Chief Operating Officer (COO)....

October 7, 2024

Synexa Life Sciences Expands Bioanalysis Capabilities with the Acquisition of CRO Alderley Analytical

Alderley Analytical offers a full range of bioanalytical services to support discovery, preclinical, and clinical drug development projects in small...

July 10, 2024

Synexa Life Sciences Enrols in My Green Lab Certification Program

Synexa Life Sciences proudly announces its enrolment in the My Green Lab Certification Program. This strategic move underscores Synexa’s commitment...

June 5, 2024

Announcing the 2024 Kimberg Internship Program: Nurturing the Next Generation of Scientific Leaders

The 2024 Kimberg Internship Program is officially underway. Take a look at what's in store for this years class of...

March 4, 2024

Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform

Synexa Life Sciences announces the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive...

February 9, 2024

Synexa Life Sciences hosts German Parliamentary Sub-Committee on Global Health at Cape Town laboratories

The visit highlighted the importance of South Africa and Synexa Life Sciences as partners in the CEPI (Coalition for Epidemic...

May 30, 2023

Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response

Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness....

March 3, 2023

Synexa Life Sciences celebrates its 20th anniversary

Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights....

Improving the quality of human health

Contact us

Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline

Talk to our Biomarker Experts